Investing
Proceeds from other investments
Merck & Co. Proceeds from other investments decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $456.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Proceeds from other investments shows an upward trend with a 13.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026May 4, 2026
How to read this metric
An increase indicates successful liquidation of alternative assets, while a decrease suggests holding or reduced divestment activity.
Detailed definition
Cash inflows resulting from the sale, redemption, or maturity of non-marketable investment assets. This category typical...
Peer comparison
Common in large financial institutions and insurers with diversified alternative asset portfolios.
Metric ID:
klac_proceeds_from_other_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $256.50M | $256.50M | $256.50M | $180.25M | $180.25M | $180.25M | $180.25M | $500.00M | $285.00M | $704.00M | $169.00M | $260.00M | $60.00M | $50.00M | $7.00M | $456.00M | $601.00M | $575.00M | $46.00M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | -29.7% | +0.0% | +0.0% | +0.0% | +177.4% | -43.0% | +147.0% | -76.0% | +53.8% | -76.9% | -16.7% | -86.0% | >999% | +31.8% | -4.3% | -92.0% | -100.0% |
| YoY Change | — | — | — | — | -29.7% | -29.7% | -29.7% | +177.4% | +58.1% | +290.6% | -6.2% | -48.0% | -78.9% | -92.9% | -95.9% | +75.4% | +901.7% | >999% | +557.1% | -100.0% |
Range$0.00 – $704.00M
CAGR-100.0%
Avg YoY Growth+162.4%
Median YoY Growth-18.0%
Current Streak3 quarters decline
Proceeds from other investments at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s proceeds from other investments?
- Merck & Co. (MRK) reported proceeds from other investments of $0.00 in Q1 2026.
- How has Merck & Co.'s proceeds from other investments changed year-over-year?
- Merck & Co.'s proceeds from other investments decreased by 100.0% year-over-year, from $456.00M to $0.00.
- What is the long-term trend for Merck & Co.'s proceeds from other investments?
- Over 4 years (2021 to 2025), Merck & Co.'s proceeds from other investments has grown at a 13.1% compound annual growth rate (CAGR), from $1.03B to $1.68B.
- What does proceeds from other investments mean?
- Cash received from selling or maturing non-marketable investments.